A new vaccine against the winter vomiting bug, norovirus, is being tested on volunteers after preliminary findings indicated the injection elicited a “strong immune response”.
The goal of the trial, which is being conducted by 27 NHS hospitals and centres in England, Scotland and Wales, is to recruit 2,500 participants by the end of December. Volunteers will be monitored for about 25 months, with half receiving the vaccine and the other half receiving a dummy drug. Scientists anticipate that the data will demonstrate that the jab is at least 65 per cent effective.
